Viewing Study NCT02094560


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-01-07 @ 11:06 AM
Study NCT ID: NCT02094560
Status: TERMINATED
Last Update Posted: 2018-09-05
First Post: 2014-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Sponsor: CellAct Pharma GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module